Everest Medicines Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everyone. This is Yang Huang, a China Healthcare Analyst at JPMorgan based in Hong Kong. Today, welcome to our, first morning session [forEC] track. First presentation will be given by Yongqing Luo, President and CEO of, Everest Medicines.
Thank you very much. Thanks for coming early morning on the last day of the conference and also, much appreciation to JP Morgan for organizing this event to bring all of us together and thank you for the opportunity to present the Everest medicines story.
I'll skip the disclaimers. So here's a snapshot on Everest, in case some of you are not familiar with us. So we are founded in 2017. We were listed on the Hong Kong Stock Exchange in 2020. Today, we have a market cap of roughly USD2 billion.
We're invested across multiple therapeutic areas and today we have three products that are already commercially launched. We have about 800 employees globally, most of them are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
